{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:20:45Z","timestamp":1740136845021,"version":"3.37.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12955-016-0513-8","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T09:35:13Z","timestamp":1469525713000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Portuguese validation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) questionnaire"],"prefix":"10.1186","volume":"14","author":[{"given":"Ab\u00edlio","family":"Reis","sequence":"first","affiliation":[]},{"given":"James","family":"Twiss","sequence":"additional","affiliation":[]},{"given":"Margarida","family":"Vicente","sequence":"additional","affiliation":[]},{"given":"Fabienne","family":"Gon\u00e7alves","sequence":"additional","affiliation":[]},{"given":"Lu\u00edsa","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9","family":"Meireles","sequence":"additional","affiliation":[]},{"given":"Alzira","family":"Melo","sequence":"additional","affiliation":[]},{"given":"Stephen P.","family":"McKenna","sequence":"additional","affiliation":[]},{"given":"Lu\u00eds","family":"Almeida","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,7,26]]},"reference":[{"key":"513_CR1","volume-title":"Pathology of pulmonary hypertension","author":"C Wagenvoort","year":"1977","unstructured":"Wagenvoort C, Wagenvoort N. Pathology of pulmonary hypertension. 2nd ed. New York: Wiley; 1977.","edition":"2"},{"issue":"3","key":"513_CR2","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1378\/chest.103.3.844","volume":"103","author":"CA Wagenvoort","year":"1993","unstructured":"Wagenvoort CA, Mulder PGH. Thrombotic lesions in primary plexogenic arteriopathy: similar pathogenesis or complication? Chest. 1993;103(3):844\u20139.","journal-title":"Chest"},{"issue":"5","key":"513_CR3","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","volume":"115","author":"GE D\u2019Alonzo","year":"1991","unstructured":"D\u2019Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, et al. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med. 1991;115(5):343\u20139.","journal-title":"Ann Intern Med"},{"issue":"1 Suppl","key":"513_CR4","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1378\/chest.126.1_suppl.7S","volume":"126","author":"LJ Rubin","year":"2004","unstructured":"Rubin LJ. Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest. 2004;126(1 Suppl):7S\u201310S.","journal-title":"Chest"},{"issue":"25 Suppl","key":"513_CR5","doi-asserted-by":"crossref","first-page":"D34","DOI":"10.1016\/j.jacc.2013.10.029","volume":"62","author":"G Simonneau","year":"2013","unstructured":"Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 Suppl):D34\u201341.","journal-title":"J Am Coll Cardiol"},{"key":"513_CR6","doi-asserted-by":"crossref","unstructured":"Rosenblum WD. Pulmonary arterial hypertension: pathobiology, diagnosis, treatment, and emerging therapies. Cardiol Rev. 2010;18(2):58\u201363.","DOI":"10.1097\/CRD.0b013e3181cd2c9e"},{"issue":"2","key":"513_CR7","first-page":"597","volume":"136","author":"M Rubenfire","year":"2009","unstructured":"Rubenfire M, Lippo G, Bodini BD, Blasi F, Allegra L, Bossone E. Evaluating health-related quality of life, work ability, and disability in pulmonary arterial hypertension: an unmet need. Chest Am Coll Chest Physicians. 2009;136(2):597\u2013603.","journal-title":"Chest Am Coll Chest Physicians"},{"key":"513_CR8","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","volume":"334","author":"RJ Barst","year":"1996","unstructured":"Barst RJ, Rubin LJ, Long WA, Mcgoon MD, Rich S, Badesch DB, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med. 1996;334:296\u2013301.","journal-title":"N Engl J Med"},{"key":"513_CR9","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1213917","volume":"369","author":"T Pulido","year":"2013","unstructured":"Pulido T, Adzerikho I, Channick RN, Delcroix M, Gali\u00e8 N, Ghofrani H-A, et al. Macitentan and morbidity and mortality in pulmonary arterial hypertension. N Engl J Med. 2013;369:809\u201318.","journal-title":"N Engl J Med"},{"issue":"5","key":"513_CR10","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1378\/chest.126.5.1452","volume":"126","author":"S Shafazand","year":"2004","unstructured":"Shafazand S, Goldstein MK, Doyle RL, Hlatky M a, Gould MK. Health-related quality of life in patients with pulmonary arterial hypertension. Chest. 2004;126(5):1452\u20139.","journal-title":"Chest"},{"issue":"1","key":"513_CR11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1513\/AnnalsATS.201412-572OC","volume":"13","author":"SC Mathai","year":"2016","unstructured":"Mathai SC, Suber T, Khair RM, Kolb TM, Damico RL, Hassoun PM. Health-related quality of life and survival in pulmonary arterial hypertension. Ann Am Thorac Soc. 2016;13(1):31\u20139.","journal-title":"Ann Am Thorac Soc"},{"key":"513_CR12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12955-014-0130-3","volume":"12","author":"CJCS Fernandes","year":"2014","unstructured":"Fernandes CJCS, Martins BCS, Jardim CVP, Ciconelli RM, Morinaga LK, Breda AP, et al. Quality of life as a prognostic marker in pulmonary arterial hypertension. Health Qual Life Outcomes. 2014;12:130.","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"513_CR13","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.healun.2007.10.004","volume":"27","author":"M Gomberg-Maitland","year":"2008","unstructured":"Gomberg-Maitland M, Thenappan T, Rizvi K, Chandra S, Meads DM, McKenna SP. United states validation of the Cambridge pulmonary hypertension outcome review (CAMPHOR). J Heart Lung Transplant. 2008;27(1):124\u201330.","journal-title":"J Heart Lung Transplant"},{"issue":"5","key":"513_CR14","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1159\/000322475","volume":"81","author":"E Gr\u00fcnig","year":"2011","unstructured":"Gr\u00fcnig E, Ehlken N, Ghofrani A, Staehler G, Meyer FJ, Juenger J, et al. Effect of exercise and respiratory training on clinical progression and survival in patients with severe chronic pulmonary hypertension. Respiration. 2011;81(5):394\u2013401.","journal-title":"Respiration"},{"key":"513_CR15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1465-9921-6-92","volume":"6","author":"DB Taichman","year":"2005","unstructured":"Taichman DB, Shin J, Hud L, Archer-Chicko C, Kaplan S, Sager JS, et al. Health-related quality of life in patients with pulmonary arterial hypertension. Respir Res. 2005;6:92.","journal-title":"Respir Res"},{"issue":"10","key":"513_CR16","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.rmed.2008.04.016","volume":"102","author":"M Zlupko","year":"2008","unstructured":"Zlupko M, Harhay MO, Gallop R, Shin J, Archer-Chicko C, Patel R, et al. Evaluation of disease-specific health-related quality of life in patients with pulmonary arterial hypertension. Respir Med. 2008;102(10):1431\u20138.","journal-title":"Respir Med"},{"issue":"3","key":"513_CR17","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1183\/09031936.00161410","volume":"38","author":"H Chen","year":"2011","unstructured":"Chen H, De Marco T, Kobashigawa EA, Katz PP, Chang VW, Blanc PD. Comparison of cardiac and pulmonary-specific quality-of-life measures in pulmonary arterial hypertension. Eur Respir J. 2011;38(3):608\u201316.","journal-title":"Eur Respir J"},{"issue":"4","key":"513_CR18","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","volume":"369","author":"H-A Ghofrani","year":"2013","unstructured":"Ghofrani H-A, Gali\u00e8 N, Grimminger F, Gr\u00fcnig E, Humbert M, Jing Z-C, et al. Riociguat for the treatment of pulmonary arterial hypertension. N Engl J Med. 2013;369(4):330\u201340.","journal-title":"N Engl J Med"},{"issue":"7","key":"513_CR19","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jacc.2003.10.056","volume":"43","author":"BKS Sastry","year":"2004","unstructured":"Sastry BKS, Narasimhan C, Reddy NK, Raju BS. Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study. J Am Coll Cardiol. 2004;43(7):1149\u201353.","journal-title":"J Am Coll Cardiol"},{"key":"513_CR20","doi-asserted-by":"crossref","unstructured":"Matura LA, McDonough A, Carroll DL. Health-related quality of life and psychological states in patients with pulmonary arterial hypertension. J Cardiovasc Nurs. 2014;29(2):178\u201384.","DOI":"10.1097\/JCN.0b013e318275330d"},{"issue":"11","key":"513_CR21","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1445-5994.2006.01169.x","volume":"36","author":"R Chua","year":"2006","unstructured":"Chua R, Keogh AM, Byth K, O\u2019Loughlin A. Comparison and validation of three measures of quality of life in patients with pulmonary hypertension. Intern Med J. 2006;36(11):705\u201310.","journal-title":"Intern Med J"},{"issue":"4","key":"513_CR22","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1183\/09031936.00127113","volume":"43","author":"J Yorke","year":"2014","unstructured":"Yorke J, Corris P, Gaine S, Gibbs JSR, Kiely DG, Harries C, et al. EmPHasis-10: development of a health-related quality of life measure in pulmonary hypertension. Eur Respir J. 2014;43(4):1106\u201313.","journal-title":"Eur Respir J"},{"key":"513_CR23","unstructured":"ClinicalTrials.gov. Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument. 2013. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01841762 ."},{"key":"513_CR24","doi-asserted-by":"crossref","unstructured":"Velanovich V. Comparison of generic (SF-36) vs. disease-specific (GERD-HRQL) quality-of-life scales for gastroesophageal reflux disease. J Gastrointest Surg. 1998;2(2):141\u20135.","DOI":"10.1016\/S1091-255X(98)80004-8"},{"issue":"4","key":"513_CR25","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00005650-199804000-00005","volume":"36","author":"L Bessette","year":"1998","unstructured":"Bessette L, Sangha O, Kuntz KM, Keller RB, Lew RA, Fossel AH, et al. Comparative responsiveness of generic versus disease-specific and weighted versus unweighted health status measures in carpal tunnel syndrome. Med Care. 1998;36(4):491\u2013502.","journal-title":"Med Care"},{"issue":"11","key":"513_CR26","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/00005650-199711000-00003","volume":"35","author":"C Jenkinson","year":"1997","unstructured":"Jenkinson C, Gray A, Doll H, Lawrence K, Keoghane S, Layte R. Evaluation of index and profile measures of health status in a randomized controlled trial. Comparison of the medical outcomes study 36-item short form health survey, EuroQol, and disease specific measures. Med Care. 1997;35(11):1109\u201318.","journal-title":"Med Care"},{"issue":"5","key":"513_CR27","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ijnurstu.2012.07.017","volume":"50","author":"SWM Weldam","year":"2013","unstructured":"Weldam SWM, Schuurmans MJ, Liu R, Lammers J-WJ. Evaluation of quality of life instruments for use in COPD care and research: a systematic review. Int J Nurs Stud. 2013;50(5):688\u2013707.","journal-title":"Int J Nurs Stud"},{"issue":"2","key":"513_CR28","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.rmed.2006.04.023","volume":"101","author":"MA Puhan","year":"2007","unstructured":"Puhan MA, Guyatt GH, Goldstein R, Mador J, Mckim D, Stahl E, et al. Relative responsiveness of the chronic respiratory questionnaire, St. Georges respiratory questionnaire and four other health-related quality of life instruments for patients with chronic lung disease. Respir Med. 2007;101(2):308\u201316.","journal-title":"Respir Med"},{"issue":"1","key":"513_CR29","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0895-4356(02)00537-1","volume":"56","author":"S Wiebe","year":"2003","unstructured":"Wiebe S, Guyatt G, Weaver B, Matijevic S, Sidwell C. Comparative responsiveness of generic and specific quality-of-life instruments. J Clin Epidemiol. 2003;56(1):52\u201360.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"513_CR30","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11136-005-3513-4","volume":"15","author":"SP McKenna","year":"2006","unstructured":"McKenna SP, Doughty N, Meads DM, Doward LC, Pepke-Zaba J. The Cambridge pulmonary hypertension outcome review (CAMPHOR): a measure of health-related quality of life and quality of life for patients with pulmonary hypertension. Qual Life Res. 2006;15(1):103\u201315.","journal-title":"Qual Life Res"},{"issue":"2","key":"513_CR31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1155\/2008\/767126","volume":"15","author":"D Coffin","year":"2008","unstructured":"Coffin D, Duval K, Martel S, Granton J, Lefebvre M-C, Meads DM, et al. Adaptation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) into French-Canadian and English-Canadian. Can Respir J. 2008;15(2):77\u201383.","journal-title":"Can Respir J"},{"issue":"8","key":"513_CR32","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/j.1440-1843.2011.02030.x","volume":"16","author":"L Ganderton","year":"2011","unstructured":"Ganderton L, Jenkins S, McKenna SP, Gain K, Fowler R, Twiss J, et al. Validation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) for the Australian and New Zealand population. Respirology. 2011;16(8):1235\u201340.","journal-title":"Respirology"},{"issue":"8","key":"513_CR33","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1177\/1403494812464445","volume":"40","author":"N Selimovic","year":"2012","unstructured":"Selimovic N, Rundqvist B, Kj\u00f6rk E, Viriden J, Twiss J, McKenna SP. Adaptation and validation of the Cambridge pulmonary hypertension outcome review for Sweden. Scand J Public Health. 2012;40(8):777\u201383.","journal-title":"Scand J Public Health"},{"key":"513_CR34","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1477-7525-10-110","volume":"10","author":"K Cima","year":"2012","unstructured":"Cima K, Twiss J, Speich R, McKenna SP, Gr\u00fcnig E, K\u00e4hler CM, et al. The German adaptation of the Cambridge pulmonary hypertension outcome review (CAMPHOR). Health Qual Life Outcomes. 2012;10:110.","journal-title":"Health Qual Life Outcomes"},{"key":"513_CR35","doi-asserted-by":"crossref","unstructured":"Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). 2015. http:\/\/dx.doi.org\/10.1093\/eurheartj\/ehv317 .","DOI":"10.1093\/eurheartj\/ehv317"},{"key":"513_CR36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1477-7525-6-65","volume":"6","author":"SP McKenna","year":"2008","unstructured":"McKenna SP, Ratcliffe J, Meads DM, Brazier JE. Development and validation of a preference based measure derived from the Cambridge pulmonary hypertension outcome review (CAMPHOR) for use in cost utility analyses. Health Qual Life Outcomes. 2008;6:65.","journal-title":"Health Qual Life Outcomes"}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-016-0513-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T15:12:25Z","timestamp":1498317145000},"score":1,"resource":{"primary":{"URL":"http:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/s12955-016-0513-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,26]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["513"],"URL":"https:\/\/doi.org\/10.1186\/s12955-016-0513-8","relation":{},"ISSN":["1477-7525"],"issn-type":[{"type":"electronic","value":"1477-7525"}],"subject":[],"published":{"date-parts":[[2016,7,26]]},"article-number":"110"}}